Gilboa, Suzanne M.

Update: characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status - United States, January 22-October 3, 2020

Zambrano, L. D., Ellington, S., Strid, P., Galang, R. R., Oduyebo, T., Tong, V. T., Woodworth, K. R., Nahabedian, J. F., Azziz-Baumgartner, E., Gilboa, S. M., et al. (2020) · MMWR Morbidity and Mortality Weekly Report

COVID-19 Impact on ReproductionCOVID-19 Clinical Research Studies

Cited by 1,207

Characteristics of women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status - United States, January 22-June 7, 2020

Ellington, S., Strid, P., Tong, V. T., Woodworth, K., Galang, R. R., Zambrano, L. D., Nahabedian, J., Anderson, K., & Gilboa, S. M. (2020) · MMWR. Morbidity and Mortality Weekly Report

COVID-19 Impact on ReproductionCOVID-19 Clinical Research Studies

Cited by 1,065

Preventable health and cost burden of adverse birth outcomes associated with pregestational diabetes in the United States

Peterson, C., Grosse, S. D., Li, R., Sharma, A. J., Razzaghi, H., Herman, W. H., & Gilboa, S. M. (2015) · American Journal of Obstetrics and Gynecology

Gestational Diabetes Research and ManagementMaternal and Neonatal Healthcare

Cited by 130

Using insurance claims data to identify and estimate critical periods in pregnancy: An application to antidepressants

Ailes, E. C., Simeone, R. M., Dawson, A. L., Petersen, E. E., & Gilboa, S. M. (2016) · Birth Defects Research Part A: Clinical and Molecular Teratology

Pregnancy and Medication ImpactMaternal Mental Health During Pregnancy and Postpartum

Cited by 112